ArticleNature communications2026
Asymmetric alloying for heterogeneous metal-ion clusters of chiral-at-carbon CAu
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Well-defined subnano-sized metal clusters are highly susceptible to changes in the type, number and arrangement of the metals. Precise alloying and stereocontrol of metal clusters at the atomic level are therefore expected to elucidate unexplored structures and functions. Here, we report an asymmetric alloying method by adding silver trifluoroacetate to a highly symmetric C-centered hexagold(I) cluster protected by triphenylphosphine, and provide detailed descriptions of the structure and propertied of the resulting chiral-at-carbon hexasilver(I)-alloyed tetragoldmethane, CAu
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.